Related Experiment Video
Updated: Aug 6, 2026

Passaging HuES Human Embryonic Stem Cell-lines with Trypsin.
Published on: October 12, 2006
Abstract:
Studies of 47 patients with intravenous amphotericin B revealed some impairment of renal function in all cases. Azotemia developed in 46 cases. Microscopic examination in eight cases showed damage to the distal renal tubule. Profound hypokalemia was recognized in two cases; and symptoms suggesting hypokalemia, which were generally ameliorated by potassium administration, were noted in most cases. It is postulated that the initial potassium loss is due to a "tubular leak" and that subsequent potassium depletion leads to further tubular damage. Mild to severe anemia developed in all cases during therapy. Serial red cell indices, bone marrow examinations and red cell survival studies indicated that hemolysis, rather than bone marrow depression, was responsible.The decision to treat, to modify therapy or to terminate treatment must be made on the basis of severity of disease, probability of progression, and renal status.
Insights
Amphotericin B treatment in 47 patients caused kidney damage, azotemia, and hypokalemia in most cases. Anemia was also common, resulting from hemolysis rather than bone marrow issues.
Area of Science:
- Nephrology
- Hematology
- Pharmacology
Background:
- Amphotericin B is a critical antifungal medication.
- Renal and hematologic toxicity are known side effects.
- Understanding the precise mechanisms and clinical impact is essential.
Purpose of the Study:
- To evaluate the renal and hematologic effects of intravenous amphotericin B.
- To investigate the incidence and nature of renal dysfunction and anemia.
- To elucidate the underlying mechanisms of observed toxicities.
Main Methods:
- Retrospective analysis of 47 patients receiving intravenous amphotericin B.
- Monitoring of renal function (azotemia) and electrolytes (potassium).
- Microscopic examination of renal tissue and hematologic parameters (red cell indices, bone marrow, red cell survival).
Main Results:
- All 47 patients exhibited some renal function impairment.
- Azotemia occurred in 46 patients; renal tubule damage was observed in 8.
- Hypokalemia was noted in most patients, and all developed mild to severe anemia due to hemolysis.
Conclusions:
- Intravenous amphotericin B frequently causes significant renal impairment, including azotemia and tubular damage.
- Hypokalemia and hemolysis-leading anemia are common adverse effects.
- Treatment decisions require careful consideration of disease severity versus potential renal and hematologic toxicity.
More Related Videos
06:49Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
12:29Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Related Concept Videos
Physical Properties of Amines
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Bioactivation and Tissue Toxicity
Cryptococcal Meningitis
Antifungal Agents
Antiprotozoal Agents